Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

mNGS

Home » mNGS
Professor SiZhou Feng : The Application of mNGS in Hematological Infections and the Optimization of Empirical Treatment Plans for Neutropenia-Associated Fever

Professor SiZhou Feng : The Application of mNGS in Hematological Infections and the Optimization of Empirical Treatment Plans for Neutropenia-Associated Fever

Posted by By Yin, Jiale 2024.01.26
Editor's Note: At the recently held Fourth China Hematology Development Conference, the "Chinese Expert Consensus on the Application of Metagenomic Next-Generation Sequencing (mNGS) in the Diagnosis of Infectious Pathogens in…
Read More
Multidisciplinary Perspective: Professor MingGui Wang  Shares Insights on the Application of mNGS in Blood Disease Infection Detection and Progress in Global CRO New Drug Treatment

Multidisciplinary Perspective: Professor MingGui Wang  Shares Insights on the Application of mNGS in Blood Disease Infection Detection and Progress in Global CRO New Drug Treatment

Posted by By Yin, Jiale 2024.01.26
Editor's Note: In recent years, the problem of drug resistance has intensified, and carbapenem-resistant organisms (CRO), representing multiple drug-resistant bacteria, have imposed a significant disease burden globally. Patients with blood diseases…
Read More
Recent Posts
  • ESMO China Voice | Professor Jiesong Wang: The iPET-NCCN-IPI Model May Optimize Risk Stratification in Diffuse Large B-Cell Lymphoma
  • ESMO China Voice | Dr. Sicong Zhang: Refractory DLBCL Patients Share Similar Immune Signatures
  • ESMO China Voice | Dr. Cong Sun: Grade 3B Follicular Lymphoma Is an Independent Risk Factor Affecting Both PFS and OS
  • ESMO China Voice | Prof. Liang Wang: CD19/CD22 Bispecific CAR-T Therapy Demonstrates Remarkable Efficacy and Safety in R/R LBCL
  • 13th FACO Annual Academic Conference Grandly Held in Shanghai! Leading Experts from China, Japan, and South Korea Gather to Foster Clinical Oncology
Recent Comments
    Archives
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top